Show
Sort by
-
Is PIPAC a treatment option in upper and lower gastrointestinal cancer with peritoneal metastasis?
-
- Journal Article
- A1
- open access
Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis
-
- Journal Article
- A1
- open access
Preclinical in vivo-models to investigate HIPEC : current methodologies and challenges
-
Incidentally found mucinous epithelial tumors of the appendix with or without pseudomyxoma peritonei : diagnostic and therapeutic algorithms based on current evidence
-
Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) versus surgery without HIPEC for goblet-cell carcinoids and mixed adenoneuroendocrine carcinomas : propensity score-matched analysis of centers in the Netherlands and Belgium
-
Intraperitoneal chemotherapy for peritoneal metastases : an expert opinion
-
- Journal Article
- A1
- open access
Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model
-
Pooled analysis of the surgical treatment for colorectal cancer liver metastases
-
- Journal Article
- A1
- open access
BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis
-
Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis